Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection — 2-Year Outcomes

In this follow-up report of a trial of CMV hyperimmune globulin in pregnant women with primary CMV infection, hyperimmune globulin did not improve hearing or developmental outcomes in children at the age of 2 years.

Saved in:

Bibliographic Details
Published in:	The New England journal of medicine Vol. 389; no. 19; pp. 1822 - 1824
Main Authors:	Hughes, Brenna L., Clifton, Rebecca G., Rouse, Dwight J., Saade, George R., Dinsmoor, Mara J., Reddy, Uma M., Pass, Robert, Allard, Donna, Mallett, Gail, MacPherson, Cora, Wapner, Ronald, Metz, Torri, Goodnight, William H., Tita, Alan T.N., Costantine, Maged M., Swamy, Geeta K., Heyborne, Kent D., Chien, Edward K., Chauhan, Suneet P., El-Sayed, Yasser Y., Casey, Brian M., Parry, Samuel, Simhan, Hyagriv N., Napolitano, Peter G., Macones, George A.
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 09-11-2023
Subjects:	Child development Childhood Diseases Congenital diseases Convulsions & seizures Cytomegalovirus Cytomegalovirus Infections - congenital Cytomegalovirus Infections - immunology Cytomegalovirus Infections - therapy Disability Female Globulins Growth and Development Gynecology Gynecology General Hearing loss Humans Hypothesis testing Immunoglobulins - therapeutic use Immunoglobulins, Intravenous - therapeutic use Infections Infectious Disease Neonatology Obstetrics Pediatrics Pediatrics General Pregnancy Pregnancy Complications, Infectious - etiology Pregnancy Complications, Infectious - immunology Pregnancy Complications, Infectious - therapy Treatment Outcome Viral Infections United States > US
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!